全文获取类型
收费全文 | 15223篇 |
免费 | 1007篇 |
国内免费 | 88篇 |
专业分类
耳鼻咽喉 | 156篇 |
儿科学 | 285篇 |
妇产科学 | 259篇 |
基础医学 | 2042篇 |
口腔科学 | 154篇 |
临床医学 | 1338篇 |
内科学 | 3614篇 |
皮肤病学 | 406篇 |
神经病学 | 1611篇 |
特种医学 | 708篇 |
外科学 | 2677篇 |
综合类 | 32篇 |
一般理论 | 2篇 |
预防医学 | 658篇 |
眼科学 | 138篇 |
药学 | 1021篇 |
中国医学 | 19篇 |
肿瘤学 | 1198篇 |
出版年
2024年 | 9篇 |
2023年 | 102篇 |
2022年 | 57篇 |
2021年 | 463篇 |
2020年 | 235篇 |
2019年 | 461篇 |
2018年 | 547篇 |
2017年 | 366篇 |
2016年 | 367篇 |
2015年 | 454篇 |
2014年 | 694篇 |
2013年 | 806篇 |
2012年 | 1295篇 |
2011年 | 1326篇 |
2010年 | 737篇 |
2009年 | 708篇 |
2008年 | 1067篇 |
2007年 | 1010篇 |
2006年 | 1026篇 |
2005年 | 914篇 |
2004年 | 872篇 |
2003年 | 717篇 |
2002年 | 690篇 |
2001年 | 134篇 |
2000年 | 106篇 |
1999年 | 135篇 |
1998年 | 126篇 |
1997年 | 110篇 |
1996年 | 68篇 |
1995年 | 73篇 |
1994年 | 68篇 |
1993年 | 45篇 |
1992年 | 67篇 |
1991年 | 48篇 |
1990年 | 45篇 |
1989年 | 46篇 |
1988年 | 47篇 |
1987年 | 32篇 |
1986年 | 28篇 |
1985年 | 22篇 |
1984年 | 18篇 |
1983年 | 18篇 |
1982年 | 14篇 |
1975年 | 14篇 |
1974年 | 14篇 |
1972年 | 13篇 |
1971年 | 13篇 |
1970年 | 18篇 |
1969年 | 14篇 |
1968年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 781 毫秒
1.
2.
3.
4.
5.
6.
7.
M. Larsabal S. Ly E. Sbidian M. Moyal-Barracco J.-N. Dauendorffer N. Dupin M.A. Richard O. Chosidow M. Beylot-Barry 《The British journal of dermatology》2019,180(3):647-656
Psoriasis is a common chronic inflammatory skin disease, affecting about 3% of the general population and approximately 2.5 million people in France, where this study took place. The genital area may be affected, however prevalence is poorly understood, meaning we do not know exactly how commonly this occurs. While it affects quality of life, genital psoriasis is under-recognized, probably due to the reluctance of patients to discuss genital involvement and sexual quality of life. The aims of this study, called the GENIPSO study, were to determine the prevalence of genital psoriasis, its clinical characteristics (its symptoms), whether it is associated with a particular type of psoriasis, and its impact on quality of life. The study included 776 adults seeing their doctor for psoriasis between November 2016 and March 2017. Among them, 336 (43.2%) had genital psoriasis. All these patients were aware that they had psoriasis on their genitals (genital lesions) but only 135 (40%) had already had a genital medical examination. Genital lesions were associated with (linked to) male gender, more severe psoriasis, first developing psoriasis when aged over 20 years, psoriasis of the skin folds, psoriasis on the scalp, nail and external auditory (ear) canal, but they were not associated with obesity or psoriatic arthritis. Itching was the main symptom. Genital psoriasis was associated with reduced quality of life and sexual health. The study found that genital psoriasis has a high prevalence in patients seeing their doctors about their psoriasis generally, it affects quality of life and should be better taken into account by dermatologists for the best possible care for patients. 相似文献
8.
9.
M. Masson Regnault J. Castañeda-Sanabria M.H.T. Diep Tran M. Beylot-Barry H. Bachelez N. Beneton O. Chosidow A. Dupuy P. Joly D. Jullien E. Mahé M.-A. Richard M. Viguier F. Tubach E. Sbidian C. Paul The PsoBioTeq Study Group 《Journal of the European Academy of Dermatology and Venereology》2020,34(2):293-300
10.
Thierry Patrice David Olivier Ludovic Bourre 《Journal of environmental pathology, toxicology and oncology》2006,25(1-2):467-485
Photodynamic therapy (PDT) is based on the selective light activation of an exogenously given drug to patients. PDT acts mainly on cell membranes either of neovascular endothelial cells or of cancer cells leading to cancer cell death. Six drugs are now marketed based on clinical assays in various indications, which showed a clear cost efficiency as compared to other classical procedures. PDT is easy to handle and can be performed in medical installations fitting the conditions of health care in developing countries. Its cost effectiveness could represent an appropriate solution to the increasing number of cancers of various origin. However despite all the clinical results now available, PDT development remains slow. The reasons for this situation include cost of development, intellectual property, and competition between pharmaceutical companies. 相似文献